expressed as a percentage of the total haemoglobin. Our laboratory reference range is 5*3-8-8% representing 2 SD limits of the mean in normal paediatric departments. Forty three patients with cystic fibrosis had a mean (SD) HbA, concentration of 7-8 (09)%, range 5-9-8 8. This was not statistically different from the mean HbAj concentration of 7*4 (094)% of 21 normal children admitted for routine operations. All the patients with cystic fibrosis were on long term antibiotic prophylaxis mainly with 0i lactam antibiotics. HbA1 concentrations were obtained on each of the 43 patients with cystic fibrosis on one to four occasions. There was no statistical difference between the mean HbA1 concentration of 7-6 (0-9)% (n=43) of the patients treated with flucloxacillin for at least a two to three month period before estimation and the mean HbA, concentration of 7-7 (08)% (n=24) for patients on both flucloxacillin and ampicillin. These did not differ from the HbA, concentrations of the control population. We found evidence of impaired i cell function in patients with raised HbA, concentrations by measurement of C pe?tide concentrations during oral glucose tolerance test.
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expressed as a percentage of the total haemoglobin. Our laboratory reference range is 5*3-8-8% representing 2 SD limits of the mean in normal paediatric departments. Forty three patients with cystic fibrosis had a mean (SD) HbA, concentration of 7-8 (09)%, range 5-9-8 8. This was not statistically different from the mean HbAj concentration of 7*4 (094)% of 21 normal children admitted for routine operations. All the patients with cystic fibrosis were on long term antibiotic prophylaxis mainly with 0i lactam antibiotics. HbA1 concentrations were obtained on each of the 43 patients with cystic fibrosis on one to four occasions. There was no statistical difference between the mean HbA1 concentration of 7-6 (0-9)% (n=43) of the patients treated with flucloxacillin for at least a two to three month period before estimation and the mean HbA, concentration of 7-7 (08)% (n=24) for patients on both flucloxacillin and ampicillin. These did not differ from the HbA, concentrations of the control population. We found evidence of impaired i cell function in patients with raised HbA, concentrations by measurement of C pe?tide concentrations during oral glucose tolerance test.
Thus there was no evidence from our study that 0i lactam antibodies produce falsely raised HbAI concentrations using the Biorad method. Although Fluckiger reports a potential problem, the evidence that it should deter the measurement of HbAt in patients with cystic fibrosis other than by specific techniques is lacking.
